Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole: Retrospective Analysis of Adverse Events in 31 Clinical Trials

By Estborn Lennart   Joelson Svante  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 627-636

Adis International

Access to resources Recommend Favorite

Community-acquired infections - the role of gatifloxacin

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Clarithromycin extended-release in community-acquired respiratory tract infections

By Williams Kathy N   Bishai William R  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2867-2876

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Newer Oral Cephalosporins: Implications for Treatment of Community-Acquired Lower Respiratory Tract Infections

By Cazzola M.   Matera M.G.   Donner C.F.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 335-346

Adis International

Access to resources Recommend Favorite

Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections

By Barman Balfour J.A.   Lamb H.M.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 115-139

Adis International

Access to resources Recommend Favorite